Postinhibitory overshoot of insulin release by gastric inhibitory polypeptide

David G Johnson, V. Conley

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Following intravenous infusion of somatostatin in vivo occasionally there is a large rebound overshoot of insulin release. An in vitro model to simulate this phenomenon was made by perfusing rat pancreas with gastric inhibitory polypeptide (GIP) during simultaneous perfusion with somatostatin. Adding GIP (100 ng/ml) to the perfusate for 2 minutes beginning either 3 or 9 minutes before terminating the somatostatin perfusion produced a large overshoot in insulin release. The magnitude of overshoot was greater when medium contained 300 mg/dl glucose that when it contained 150 mg/dl glucose. Perfusion with GIP for 2 minutes beginning 9 minutes before increasing the glucose concentration of the medium from 30 to 300 mg/dl elicited a large increase in both the acute and second-phase release of insulin. These suggest that post-inhibitory overshoot of insulin release after somatostatin may be produces in vitro by the suppressed action of stimulatory hormones such as GIP. Prior infusion with GIP can also potentiate glucose-stimulated insulin increase.

Original languageEnglish (US)
Pages (from-to)2373-2380
Number of pages8
JournalLife Sciences
Volume27
Issue number24
DOIs
StatePublished - Dec 15 1980

Fingerprint

Gastric Inhibitory Polypeptide
Somatostatin
Insulin
Glucose
Perfusion
Intravenous Infusions
Rats
Pancreas
Hormones

ASJC Scopus subject areas

  • Pharmacology

Cite this

Postinhibitory overshoot of insulin release by gastric inhibitory polypeptide. / Johnson, David G; Conley, V.

In: Life Sciences, Vol. 27, No. 24, 15.12.1980, p. 2373-2380.

Research output: Contribution to journalArticle

@article{33f60e4915384c87b785ef5a4083910c,
title = "Postinhibitory overshoot of insulin release by gastric inhibitory polypeptide",
abstract = "Following intravenous infusion of somatostatin in vivo occasionally there is a large rebound overshoot of insulin release. An in vitro model to simulate this phenomenon was made by perfusing rat pancreas with gastric inhibitory polypeptide (GIP) during simultaneous perfusion with somatostatin. Adding GIP (100 ng/ml) to the perfusate for 2 minutes beginning either 3 or 9 minutes before terminating the somatostatin perfusion produced a large overshoot in insulin release. The magnitude of overshoot was greater when medium contained 300 mg/dl glucose that when it contained 150 mg/dl glucose. Perfusion with GIP for 2 minutes beginning 9 minutes before increasing the glucose concentration of the medium from 30 to 300 mg/dl elicited a large increase in both the acute and second-phase release of insulin. These suggest that post-inhibitory overshoot of insulin release after somatostatin may be produces in vitro by the suppressed action of stimulatory hormones such as GIP. Prior infusion with GIP can also potentiate glucose-stimulated insulin increase.",
author = "Johnson, {David G} and V. Conley",
year = "1980",
month = "12",
day = "15",
doi = "10.1016/0024-3205(80)90507-X",
language = "English (US)",
volume = "27",
pages = "2373--2380",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "24",

}

TY - JOUR

T1 - Postinhibitory overshoot of insulin release by gastric inhibitory polypeptide

AU - Johnson, David G

AU - Conley, V.

PY - 1980/12/15

Y1 - 1980/12/15

N2 - Following intravenous infusion of somatostatin in vivo occasionally there is a large rebound overshoot of insulin release. An in vitro model to simulate this phenomenon was made by perfusing rat pancreas with gastric inhibitory polypeptide (GIP) during simultaneous perfusion with somatostatin. Adding GIP (100 ng/ml) to the perfusate for 2 minutes beginning either 3 or 9 minutes before terminating the somatostatin perfusion produced a large overshoot in insulin release. The magnitude of overshoot was greater when medium contained 300 mg/dl glucose that when it contained 150 mg/dl glucose. Perfusion with GIP for 2 minutes beginning 9 minutes before increasing the glucose concentration of the medium from 30 to 300 mg/dl elicited a large increase in both the acute and second-phase release of insulin. These suggest that post-inhibitory overshoot of insulin release after somatostatin may be produces in vitro by the suppressed action of stimulatory hormones such as GIP. Prior infusion with GIP can also potentiate glucose-stimulated insulin increase.

AB - Following intravenous infusion of somatostatin in vivo occasionally there is a large rebound overshoot of insulin release. An in vitro model to simulate this phenomenon was made by perfusing rat pancreas with gastric inhibitory polypeptide (GIP) during simultaneous perfusion with somatostatin. Adding GIP (100 ng/ml) to the perfusate for 2 minutes beginning either 3 or 9 minutes before terminating the somatostatin perfusion produced a large overshoot in insulin release. The magnitude of overshoot was greater when medium contained 300 mg/dl glucose that when it contained 150 mg/dl glucose. Perfusion with GIP for 2 minutes beginning 9 minutes before increasing the glucose concentration of the medium from 30 to 300 mg/dl elicited a large increase in both the acute and second-phase release of insulin. These suggest that post-inhibitory overshoot of insulin release after somatostatin may be produces in vitro by the suppressed action of stimulatory hormones such as GIP. Prior infusion with GIP can also potentiate glucose-stimulated insulin increase.

UR - http://www.scopus.com/inward/record.url?scp=0019196814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019196814&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(80)90507-X

DO - 10.1016/0024-3205(80)90507-X

M3 - Article

C2 - 6111012

AN - SCOPUS:0019196814

VL - 27

SP - 2373

EP - 2380

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 24

ER -